Imipenem/cilastatin reduces cyclosporin-induced tubular damage in kidney transplant recipients

Transplantation Proceedings

Volumn 30, Issue 5, 1998, Pages 2034-2035

  Carmellini, M ^a,b   Matteucci, E ^a   Boggi, U ^a   Cecconi, S ^a   Giampietro, O ^a   Mosca, F ^a  

^a UNIVERSITY OF PISA   (Italy)

^b CISANELLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CILASTATIN; CYCLOSPORIN; IMIPENEM;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; FOLLOW UP; HLA SYSTEM; HUMAN; KIDNEY GRAFT; KIDNEY INJURY; KIDNEY TRANSPLANTATION; NEPHROTOXICITY; PRIORITY JOURNAL; TREATMENT OUTCOME; URINARY EXCRETION; URINE VOLUME;

ACETYLGLUCOSAMINIDASE; ALBUMINURIA; ANTIBIOTIC PROPHYLAXIS; CEFTAZIDIME; CILASTATIN; CREATININE; CYCLOSPORINE; DIURESIS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMIPENEM; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; LIPOPROTEINS; PROTEASE INHIBITORS; THIENAMYCINS;

EID: 0031704488     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)00523-5     Document Type: Conference Paper

References (8)

1. Suthanthiran M, Strom TB: N Engl J Med 332:365, 1994
2. Massy ZA, Guijarro C, Wiederkehr MR, et al: Kidney Int 49:518, 1996
3. Price RG: Toxicology 23:99, 1982
4. Markewitz A, Hammer C, Pfeiffer M: et al: Transplantation 57:865, 1994
5. Maruhn D, Paar D: In Burlina A, Galzigna L, (eds): Clinical Enzymol Symposia III. 1982, p 137
6. Carmellini M, Frosini F, Filipponi F, et al: Transplantation 64:164, 1997
7. Baghaie A, Bayat M, Abobo C, et al: Crit Care Med 23:A241, 1995
8. Matteucci E, Carmellini M, Bertoni C, Eighth International Symposium Nephrology at Montecatini. 1996